Hong Kong, Macau stop using BioNTech vaccine amid packaging issue

Temporary suspension comes after cap defect reported, as authorities say there is no issue with vaccine’s safety.

Hong Kong and Macau have suspended the use of Pfizer-BioNTech vaccines because of a defect in the packaging of one batch of doses, officials said on Wednesday. Vials with lot number 210102 were found to have defective packaging, authorities said, and an investigation was under way. “For the sake of precaution, the current vaccination must be suspended during the period of investigation,” Hong Kong’s government said in a statement.